- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER2/Neu Positive in South Africa
Total 653 results
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
City of Hope Medical CenterNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedStage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedHER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
Molecular Templates, Inc.TerminatedHER2-positive Solid CancersUnited States, Australia, New Zealand
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingHER2/Neu Negative | Estrogen Receptor-positive Breast Cancer | Stage IV Breast Cancer AJCC v6 and v7United States
-
GeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingHER2-positive Breast Cancer | HER2-positive Biliary Tract Cancer | HER2-Positive Salivary Gland Carcinomas | HER2-Positive Advanced Solid TumorChina, Australia, United States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
National Cancer Institute (NCI)CompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | HER2/Neu PositiveUnited States, Puerto Rico
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Triple-negative Breast Carcinoma | Progesterone Receptor-negativeUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Elevated CA15-3 or CEA or CA27-29United States, Puerto Rico, Guam
-
Johns Hopkins UniversityCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Metastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Androgen Receptor PositiveUnited States
-
University of WashingtonPATH; University of KwaZulu; Umkhuseli Innovation and Research Management (UIRM) and other collaboratorsUnknownTuberculosisSouth Africa
-
Vakzine Projekt Management GmbHUniversity of Stellenbosch; Farmovs-Parexel Bloemfontein, Republic of South... and other collaboratorsCompleted
-
AerasStatens Serum InstitutCompletedTuberculosisSouth Africa
-
International AIDS Vaccine InitiativeBiofabri, S.L; South African Tuberculosis Vaccine Initiative; Universidad de...CompletedTuberculosisSouth Africa
-
Boston Medical CenterBoston University; National Institute of Allergy and Infectious Diseases (NIAID) and other collaboratorsEnrolling by invitationTuberculosis | Illicit Drug UseSouth Africa
-
National Institute of Allergy and Infectious Diseases...Completed
-
Johns Hopkins UniversityUnited States Agency for International Development (USAID)CompletedTuberculosisSouth Africa
-
University of OxfordUniversity of Cape TownCompleted
-
Statens Serum InstitutBill and Melinda Gates Foundation; Aurum Institute; Leiden University Medical... and other collaboratorsRecruiting
-
PATHWorld Health Organization; University of Cape TownCompleted
-
Boston UniversityNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompletedTuberculosis | Drug-resistant TuberculosisSouth Africa
-
GlaxoSmithKlineCompletedInfections, StreptococcalSouth Africa
-
Wellcome Trust Liverpool Glasgow Centre for Global...Professor David Lalloo; Professor Hamish Simpson; Professor William J Harrison; Professor Sithombo MaqungoUnknownFracture Healing in HIV-positive PatientsSouth Africa
-
Qurient Co., Ltd.CompletedTreatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TBSouth Africa
-
Vakzine Projekt Management GmbHUniversity of Stellenbosch; Children's Infectious Diseases Clinical Research... and other collaboratorsCompleted
-
Johns Hopkins UniversityUniversity of Witwatersrand, South AfricaCompleted
-
Mark HatherillMedical Research Council; University of Oxford; Wellcome Trust; Department for... and other collaboratorsCompletedSafety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination (MVA(TB)029)HIV | TuberculosisSouth Africa
-
AerasSanofi Pasteur, a Sanofi Company; Statens Serum Institut; HIV Vaccine Trials...CompletedTuberculosisSouth Africa
-
Statens Serum InstitutCompleted
-
Elizabeth Glaser Pediatric AIDS FoundationHarvard School of Public Health (HSPH); Centre for Infectious Disease Research... and other collaboratorsCompletedHIV Infections | Pregnant Women | HIV PositiveSouth Africa, Zambia
-
AerasStatens Serum InstitutCompletedLatent Tuberculosis | Latent Tuberculosis Bacteriology and Histology UnknownSouth Africa
-
The Aurum Institute NPCLondon School of Hygiene and Tropical Medicine; Johns Hopkins University; Aurum...CompletedHIV | TuberculosisSouth Africa
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | TuberculosisSouth Africa
-
Massachusetts General HospitalBoston University; University of Cape TownRecruitingHIV Infections | Smoking Cessation | TuberculosisSouth Africa
-
Centers for Disease Control and PreventionJohns Hopkins University; Sanofi; University of Stellenbosch; University of Cape... and other collaboratorsRecruiting
-
Professor Francois VenterUniversity of Cape TownCompletedTuberculosis | HIV-1-infectionSouth Africa
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); Human Sciences...RecruitingTuberculosisSouth Africa
-
Biofabri, S.LSouth African Tuberculosis Vaccine Initiative; TuBerculosis Vaccine Initiative and other collaboratorsCompletedTuberculosisSouth Africa
-
Biofabri, S.LSouth African Tuberculosis Vaccine Initiative; TuBerculosis Vaccine Initiative and other collaboratorsCompleted
-
Radboud University Medical CenterCompleted
-
Fundació Institut Germans Trias i PujolNational Center for Tuberculosis and Lung Disease, Tbilisi, GeorgiaCompletedTuberculosisGeorgia, South Africa
-
National Institute of Allergy and Infectious Diseases...Completed
-
University of OxfordUniversity of Cape TownCompleted
-
Oxford ImmunotecCompleted
-
Johns Hopkins UniversityCompletedTuberculosis, PulmonarySouth Africa
-
GlaxoSmithKlineAerasCompletedTuberculosisSouth Africa
-
Massachusetts General HospitalNational Institute of Allergy and Infectious Diseases (NIAID); AIDS Healthcare...Completed